SCHEMBL14038271

SCHEMBL14038271

NC(=O)C(Cc1ccccc1)NC(=O)c1ccc2[nH]c(-c3ccncc3)nc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.54
HPGDS O60760 9/20 0.51
ROCK2 O75116 3/20 0.50
ROCK1 Q13464 2/20 0.50
PKN2 Q16513 2/20 0.47
PKN1 Q16512 1/20 0.47
CHEK2 O96017 2/20 0.46
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
RPS6KA5 O75582 1/20 0.45
RPS6KA4 O75676 1/20 0.45
PRKACA P17612 1/20 0.45
MAPK1 P28482 1/20 0.45
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45
IRAK1 P51617 1/20 0.45
PRKX P51817 1/20 0.45
PRKG1 Q13976 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6222474 0.81 IKBKB (0.59) IKBKBPKN2PKN1CHEK2HDAC3
SCHEMBL6221885 0.80 IKBKB (0.58) IKBKBPKN2PKN1CHEK2HDAC3
SCHEMBL6223457 0.80 IKBKB (0.58) IKBKBPKN2PKN1CHEK2HDAC3
SCHEMBL3996824 0.78 HDAC6 (0.60) CHEK2HDAC3HDAC1HDAC8HDAC6
SCHEMBL12320657 0.77 HPGDS (0.64) HPGDSROCK2ROCK1PKN2RPS6KA5
Trifluoroacetic Acid SCHEMBL6226717 0.76 IKBKB (0.54) IKBKBPKN2PKN1HDAC3HDAC1
Trifluoroacetic Acid SCHEMBL6226719 0.76 IKBKB (0.54) IKBKBPKN2PKN1CHEK2HDAC3
SCHEMBL6220797 0.76 IKBKB (0.53) IKBKBPKN2PKN1CHEK2HDAC3
SCHEMBL7651442 0.76 IKBKB (0.53) IKBKBPKN2PKN1CHEK2HDAC3
SCHEMBL7921841 0.75 IKBKB (0.41) IKBKBROCK2ROCK1CHEK2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133884-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-11-06 WO disclosed